1 / 6

Biopsy Devices Market Size, Share, Growth and Forecast to 2020 - Hexa Research

Biopsy devices market is anticipated to witness lucrative growth over the forecast period owing to the increasing incidences of chronic diseases such as cancer, kidney diseases and other infectious diseases.

Carrol
Télécharger la présentation

Biopsy Devices Market Size, Share, Growth and Forecast to 2020 - Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Biopsy Devices Market Research Report - Industry Analysis, Size, Share and Forecast to 2020 | Hexa Research “Biopsy devices market is anticipated to witness lucrative growth over the forecast period owing to the increasing incidences of chronic diseases such as cancer, kidney diseases and other infectious diseases.” The worldwide Biopsy Devices Market is expected to grow at a nearly 6.5% CAGR over the forecast period (2012 to 2020). By 2020, the industry may report revenues worth almost USD 2.4 billion. High prevalence of infectious diseases and serious illnesses like cancer and kidney diseases can propel demand in the years to come. The removal of body tissues to rule out the growth of abnormal cells is known as biopsy. Biopsies are conducted quite frequently these days because of high incidence of deadly diseases. Growing geriatric population is a prominent factor that may fuel the industry in the years to come. Different types of biopsies in cancer diagnosis are incision, skin, excision, and shave. Popularity of minimally invasive biopsy procedures can further contribute to global demand. The biopsy devices industry is gradually expanding in most emerging nations because of greater awareness, high incomes, investment in R&D, and high healthcare expenditure. Browse Details of Report@ https://www.hexaresearch.com/research-report/biopsy-devices-industry Follow Us:

  2. Your Catalyst To a Lucrative Business Products and regions are two parameters based on which the global Biopsy Devices Market is categorized. According to products, the industry is divided into biopsy forceps, biopsy guidance system, needle-based biopsy guns, biopsy needles, and others. “Others” refers to biopsy punches, curettes, and brushes. Guidance systems held the highest share in 2013 owing to high prices of robotic guidance systems. Popularity of accurate & minimally invasive devices and high incidence of cancer are two key factors that drive this segment. It is influenced by technological advancements and the surging demand for user-friendly products. Needle-based biopsy guns is a highly profitable segment because of surging demand for the same for obtaining soft tissue samples from bone marrows, kidneys, prostate glands, lungs, and breasts. Needle-based biopsy guns are further segmented into core needle, fine needle aspiration, and vacuum assisted biopsy devices. Biopsy forceps are of two types, namely hot and cold. The cold biopsy forceps segment can expand considerably in the years to come because these help prevent the onset of infectious diseases. The market for robotic guidance systems is projected to expand remarkably over the forecast period because of surging disposable incomes and substantial investments in technology. Geographically, the global Biopsy Devices Market is classified into Europe, Asia Pacific, North America, and Rest of the World. North America held maximum shares in 2013 in terms of revenue. The region may continue dominating the overall industry throughout the forecast period because of rising prevalence of cancer and greater awareness about biopsy devices. The Asia Pacific market may grow rapidly because of a booming population and an expanding medical tourism industry. Other regional drivers are rising disposable incomes, unmet medical needs, and gradual improvements in healthcare infrastructure. Key companies operating in the worldwide industry are DTR Medical; Cardinal Health Inc.; Hologic Inc.; Devicor Medical Products Inc,; and C.R. Bard Inc. Researchers from the University of Adelaide have developed a novel medical device that could lead to safer brain surgeries. It is a smart needle that helps spot blood vessels in the body. A miniature imaging probe placed inside a brain biopsy needle enables surgeons to see those blood vessels that are prone to risks. These needles on being inserted avoid causing fatal bleeds during the procedure. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of Biopsy Devices Market Chapter 1. Executive Summary 1.1. Biopsy Devices – Industry Summary and Critical Success Factors (CSFs) Chapter 2. Biopsy Devices Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Biopsy Devices Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Biopsy Devices - Company Market Share Analysis 2.7. Biopsy Devices Market PESTEL Analysis, 2012 Chapter 3. Biopsy Devices Product Outlook 3.1. Biopsy Guidance system 3.1.1. Global Biopsy guidance systems demand by region, (USD Million), 2012 – 2020 3.1.2. Manual guidance systems market (USD million), 2012 – 2020 3.1.3. Robotic guidance systems market (USD million), 2012 - 2020 3.2. Biopsy Needles 3.2.1. Global Biopsy needles demand by region, (USD Million), 2012 – 2020 3.2.2. Disposable biopsy needles market (USD million), 2012 – 2020 3.2.3. Reusable biopsy needles market (USD million), 2012 - 2020 3.3. Needle-based Biopsy Guns 3.3.1. Global Needle based biopsy guns demand by region, (USD Million), 2012 – 2020 3.3.2. Vacuum assisted biopsy devices market (USD million), 2012 – 2020 3.3.3. Core needle biopsy devices market (USD million), 2012 – 2020 3.3.4. Fine needle aspiration devices market (USD million), 2012 - 2020 3.4. Biopsy Forceps 3.4.1. Global Biopsy forceps demand by region, (USD Million), 2012 – 2020 3.4.2. Cold forceps market (USD million), 2012 – 2020 3.4.3. Hot forceps market (USD million), 2012 - 2020 3.5. Others biopsy devices 3.5.1. Global Other biopsy devices demand by region, (USD Million), 2012 – 2020 Follow Us:

  4. Your Catalyst To a Lucrative Business 3.5.2. Biopsy brushes market (USD million), 2012 – 2020 3.5.3. Biopsy curettes market (USD million), 2012 – 2020 3.5.4. Biopsy punches market (USD million), 2012 - 2020 Chapter 4. Biopsy Devices Regional Outlook 4.1. North America 4.1.1. North America biopsy devices market revenue by product, (USD Million), 2012 – 2020 4.2. Europe 4.2.1. Europe biopsy devices market revenue by product, (USD Million), 2012 – 2020 4.3. Asia Pacific 4.3.1. Asia Pacific biopsy devices market revenue by product, (USD Million), 2012 – 2020 4.4. RoW 4.4.1. RoW biopsy devices market revenue by product, (USD Million), 2012 – 2020 Chapter 5 Biopsy Devices Competitive Landscape 5.1 Angiotech 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 Cardinal Health Inc 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Carefusion Corporation 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 C. R. BARD, Inc 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 Devicor Medical Products Inc. Follow Us:

  5. Your Catalyst To a Lucrative Business 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 DTR Medical 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Hologic, Inc 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 INRAD, Inc 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 UK Biopsy 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources Follow Us:

  6. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us:

More Related